Publications by authors named "Matthew S Wieman"

Claim this Profile
C
Changes in prevalence of prescription opioid abuse after introduction of an abuse-deterrent opioid formulation.
Theresa A Cassidy, Pronabesh DasMahapatra, Ryan A Black, Matthew S Wieman, Stephen F Butler

Pain Med· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Current topics in opioid therapy for pain management: addressing the problem of abuse.
Frank E Casty, Matthew S Wieman, Neil Shusterman

Clin Drug Investig· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term tolerability of topical diclofenac sodium 1% gel for osteoarthritis in seniors and patients with comorbidities.
John H Peniston, Morris S Gold, Matthew S Wieman, Lawrence K Alwine

Clin Interv Aging· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Response to Weingarten, "Methemoglobinemia in the setting of chronic transdermal lidocaine patch use," Pain Medicine 2012.
Matthew S Wieman, Daniela C G Bertarelli, Carina Brockbals

Pain Med· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Drug Development in the 21st Century: The Synergy of Public, Private, and International Collaboration.
Frank E Casty, Matthew S Wieman

Ther Innov Regul Sci· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validity testing of patient objections to acceptance of tamper-resistant opioid formulations.
Charles E Argoff, Steven P Stanos, Matthew S Wieman

J Pain Res· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tolerability of diclofenac sodium 1% gel with concomitant medications known to interact with diclofenac.
John H Peniston, Morris S Gold, Matthew S Wieman, Lawrence K Alwine

Ther Clin Risk Manag· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tolerability of concomitant use of selective serotonin reuptake inhibitors or serotonin-norepinephrine reuptake inhibitors and oxymorphone extended release.
John H Peniston, Xiaojun Hu, Susan L Potts, Matthew S Wieman, Dennis C Turk

Postgrad Med· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tolerability of topical diclofenac sodium 1% gel for osteoarthritis in seniors and patients with comorbidities.
Herbert S B Baraf, Morris S Gold, Richard A Petruschke, Matthew S Wieman

Am J Geriatr Pharmacother· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis